Clinical Research Advantage is categorized under Services (Unclassified) in Scottsdale, AZ and active since 2010.
Clinical Research Advantage was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Michele Avery at the company’s branch by writing to 10229 North 92nd St # 102, Scottsdale, Arizona AZ 85258 or by phoning (480) 820-5656. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Research Advantage |
| Contact Person: | Michele Avery |
| Address: | 10229 North 92nd St # 102, Scottsdale, Arizona 85258 |
| Phone Number: | (480) 820-5656 |
| Website Address: | crastudies.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 5419100 |
| Share This Business: |
Clinical Research Advantage was started in 2010 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Michele Avery for inquiries that concern Clinical Research Advantage by calling the company number (480) 820-5656, as your correspondence is most welcome. Additionally, the physical location of the branch of Clinical Research Advantage can be found at the coordinates 33.57841,-111.88059 as well as the street address 10229 North 92nd St # 102 in Scottsdale, Arizona 85258.
For its online presence, you may visit Clinical Research Advantage’s website at crastudies.com and engage with its social media outlets through on Twitter and on Facebook.